Literature DB >> 22185832

The certification of smallpox eradication and implications for guinea worm, poliomyelitis, and other diseases: confirming and maintaining a negative.

Joel G Breman1, Isao Arita.   

Abstract

Rigorous, independent, confirmation of disease eradication is necessary to assure credibility of the claimed accomplishment. The criteria and procedures for formal certification of global disease freedom are based on the biological and epidemiological features of the pathogen and its manifestations. Certification activities by previously endemic and at-risk countries include comprehensive documentation focusing on surveillance, reports of national independent review groups, and special field surveys. National and regional results are reviewed by authoritative International Commissions (ICs) which verify the findings by field visits. The ICs present their results to an independent WHO-convened group ("Global Commission" for smallpox), members of which participate in field visits. When fully satisfied, the Global Commission makes conclusions and recommendations to the World Health Assembly (WHA). Smallpox was confirmed eradicated in 1980 by the WHA less than three years after the last naturally occurring case was detected. Dracunculiasis (guinea worm) freedom has been certified in 187 countries. Regional commissions have certified the Americas, Asia, and Europe polio-free; however, re-establishment of endemic foci in countries previously declared disease-free has created special challenges for completing this program. Post-eradication activities require attention to surveillance, maximum security of the microbial agent, and essential research to assure maintenance of disease freedom.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22185832     DOI: 10.1016/j.vaccine.2011.06.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Evaluation of the integrated disease surveillance and response system for infectious diseases control in northern Ghana.

Authors:  Martin Nyaaba Adokiya; John Koku Awoonor-Williams; Inuwa Yau Barau; Claudia Beiersmann; Olaf Mueller
Journal:  BMC Public Health       Date:  2015-02-04       Impact factor: 3.295

2.  Global control of COVID-19: good vaccines may not suffice.

Authors:  Javier Eslava-Schmalbach; Eric B Rosero; Nathaly Garzón-Orjuela
Journal:  Rev Panam Salud Publica       Date:  2021-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.